World Vaccine Congress

Meet with Q2 Solutions, booth 220, and learn how we can work with you to develop customized assays to meet your drug development goals

Washington, D.C. | April 14, 2019 - April 17, 2019 | 08:00 - 18:00 Add to Calendar
Stay Informed Schedule a Meeting

About This Event

Our vaccine solutions span the entire development life cycle, including assay development, immunogenicity testing, genomic solutions, efficacy monitoring, project management and data management to meet your specific development needs.

Meet us at the World Vaccine Congress to learn how our scientific experts can help you optimize your vaccine study designs and accelerate regulatory approval.

Plan to join Q2 Solutions’ Brent Seaton, for his presentation “Comparison of Zika virus neutralization assay platforms: PRNT and RVP”, on April 16th, Conference Day 2, 12:40 pm.

We look forward to meeting you in Washington, D.C.

Related Services:

Register for Event

Keeping Up with the Flu: Advances in seasonal influenza vaccine development

Tuberculosis (TB) Testing Capabilities

State-of-the-art technologies, quality management systems, and high-quality infrastructure to address the full spectrum of your TB testing needs

Delivery Excellence for Anti-infective and Vaccine Development

Supply chain and quality management systems to ensure sample integrity for high-quality data delivery

New Approaches for Malaria Vaccine Development

How advances in genetic engineering have brought new hope to conquering malaria

A Proactive Approach to Ebola Vaccine Development

Best practices for rapid test development and regulatory approvals

Read More